ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 140 filers reported holding ACCELERON PHARMA INC in Q1 2017. The put-call ratio across all filers is 2.15 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $15,000 | +15.4% | 499 | 0.0% | 0.02% | +26.3% |
| Q1 2017 | $13,000 | 0.0% | 499 | 0.0% | 0.02% | -13.6% |
| Q4 2016 | $13,000 | -27.8% | 499 | 0.0% | 0.02% | -31.2% |
| Q3 2016 | $18,000 | +5.9% | 499 | 0.0% | 0.03% | +18.5% |
| Q2 2016 | $17,000 | +30.8% | 499 | 0.0% | 0.03% | +42.1% |
| Q1 2016 | $13,000 | -48.0% | 499 | -2.5% | 0.02% | -45.7% |
| Q4 2015 | $25,000 | +150.0% | 512 | +25.5% | 0.04% | +150.0% |
| Q3 2015 | $10,000 | -33.3% | 408 | -12.6% | 0.01% | -17.6% |
| Q2 2015 | $15,000 | – | 467 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 42,030 | $3,777,000 | 6.01% |
| Artal Group S.A. | 1,500,000 | $134,805,000 | 5.70% |
| GREAT POINT PARTNERS LLC | 535,627 | $48,137,000 | 5.03% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 211,038 | $18,966,000 | 3.47% |
| Cormorant Asset Management, LP | 825,000 | $74,143,000 | 3.44% |
| Graticule Asia Macro Advisors LLC | 48,700 | $4,377,000 | 3.20% |
| Avoro Capital Advisors LLC | 860,000 | $77,288,000 | 2.61% |
| QVT Financial LP | 120,264 | $10,808,000 | 2.52% |
| Ikarian Capital, LLC | 316,900 | $28,480,000 | 2.14% |
| Avidity Partners Management LP | 166,000 | $14,918,000 | 2.06% |